Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial

(2010) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2010) Thomas F. Hiemstra et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

(2009) M. A. Little et al.   ANNALS OF THE RHEUMATIC DISEASES

Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis

(2008) Christian Pagnoux et al.   NEW ENGLAND JOURNAL OF MEDICINE